BioNTech
BNTX
80.96
-0.42
-0.52%
BioNTech
US · BNTX
#801 by market cap
Listed 2019
80.96
-0.42
-0.52%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: BMO Capital moved from Buy to Hold on 2026-09-08.
Analyst consensus 16 analysts
Buy
Avg price target 119.33 +47.4%
Price target rangecurrent 80.96
Low93.00
Avg119.33
High140.00
Buy 75%
Hold 25%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-19 | J.P. Morgan | -- | Hold | 93.00 |
| 2026-11-16 | BofA Securities | -- | Buy | 108.00 |
| 2026-11-11 | Citi | -- | Buy | 125.00 |
| 2026-11-10 | H.C. Wainwright | -- | Buy | 110.00 |
| 2026-11-09 | Morgan Stanley | -- | Buy | 106.00 |
| 2026-11-09 | H.C. Wainwright | -- | Buy | 110.00 |
| 2026-11-06 | Bernstein | -- | Hold | 96.00 |
| 2026-11-04 | CCORF | -- | Buy | 132.00 |
| 2026-11-04 | Wells Fargo | -- | Buy | 125.00 |
| 2026-11-04 | UBS | -- | Buy | 125.00 |
| 2026-11-04 | Jefferies | -- | Buy | 138.00 |
| 2026-11-04 | Goldman Sachs | -- | Buy | 127.00 |
| 2026-11-03 | BofA Securities | -- | Buy | 108.00 |
| 2026-11-03 | BMO Capital | -- | Hold | 95.00 |
| 2026-11-02 | Morgan Stanley | -- | Buy | 106.00 |
| 2026-10-27 | CCORF | -- | Buy | 132.00 |
| 2026-10-27 | BofA Securities | -- | Buy | 114.00 |
| 2026-10-27 | Citi | -- | Buy | 125.00 |
| 2026-10-27 | J.P. Morgan | -- | Hold | -- |
| 2026-10-26 | UBS | -- | Buy | 135.00 |
| 2026-10-26 | BofA Securities | -- | Buy | 114.00 |
| 2026-10-26 | Morgan Stanley | -- | Buy | 114.00 |
| 2026-10-26 | Citi | -- | Buy | 125.00 |
| 2026-10-23 | CCORF | -- | Buy | 132.00 |
| 2026-10-19 | CCORF | -- | Buy | 132.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-08 | BMO Capital | Buy → Hold | 105.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | -- | ±8.41% | -0.70% (in line) |
| 2026/Q2 | 2026-08-04 | -- | ±7.30% | -0.98% (in line) |
| 2026/Q1 | 2026-05-05 | -- | ±7.38% | -3.88% (in line) |
| 2025/Q4 | 2026-03-10 | -- | ±6.66% | -17.88% (beat) |
| 2025/Q3 | 2025-11-03 | -- | ±7.06% | +0.04% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±8.63% | +2.51% (in line) |
| 2025/Q1 | 2025-05-05 | -- | ±10.75% | -3.66% (in line) |
| 2024/Q4 | 2025-03-10 | -- | ±10.78% | -3.15% (in line) |
| 2024/Q3 | 2024-11-04 | -- | ±9.54% | -2.25% (in line) |
| 2024/Q2 | 2024-08-05 | -- | ±6.25% | -4.45% (in line) |
| 2024/Q1 | 2024-05-06 | -- | ±6.40% | +0.68% (in line) |
| 2023/Q4 | 2024-03-20 | -- | ±10.06% | -4.38% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
BioNTech discussion 0 comments